Drug intelligence / Profile preview

Ad-p16

Development stage
Unknown
Lead developer
Shanghai Sunway Biotech
Modality
Oncolytic Viruses → Oncolytic Therapeutics, Gene Therapies
Administration
Intratumoral, Intra-arterial
01

Overview

Ad-p16 is an investigational gene therapy in which an adenoviral vector (Ad) delivers the human p16 gene to target cells, aiming to restore or enhance expression of p16, a cyclin-dependent kinase inhibitor with tumor suppressor activity. The p16 protein slows cell division by inhibiting cell cycle progression from G1 to S phase, making it a critical regulator of cellular senescence and a tumor suppressor implicated in a range of cancers. Ad-p16 is primarily being studied for cancers where CDKN2A (the gene encoding p16) is inactivated or its product is deficient, with the intended mechanism to restore the tumor-suppressive cell cycle arrest in malignant cells[1][3][5].

Other names
Ad-p16Ad-p-16Ad-p 16
02

Targets

CDK6 (Cyclin-dependent kinase 6)CDK4 (Cyclin-dependent kinase 4)

Beyond the preview

Go deeper on Ad-p16.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ad-p16.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call